Paper41234722
High BMI-attributable female-specific cancers: a comprehensive analysis of the global disease burden and trends from 1990 to 2021 and projections to 2040.
Sun G and 6 others. Front Oncol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. High BMI-attributable female-specific cancers: a comprehensive analysis of the global disease burden and trends from 1990 to 2021 and projections to 2040. Papers, record 41234722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41234722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High BMI-attributable female-specific cancers: a comprehensive analysis of the global disease burden and trends from 1990 to 2021 and projections to 2040.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36650483 | Disease burden and attributable risk factors of neonatal disorders and their specific causes in China from 1990 to 2019 and its prediction to 2024. | BMC Public Health | 2023 | https://conductscience.org/library/papers/36650483 | PubMed |
| 2 | 29021522 | The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. | Nat Commun | 2017 | https://conductscience.org/library/papers/29021522 | PubMed |
| 3 | 39853979 | Incidence Rate Trends of Breast Cancer Overall and by Molecular Subtype by Race and Ethnicity and Age. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/39853979 | PubMed |
| 4 | 38400738 | Association between diet quality and ovarian cancer risk and survival. | J Natl Cancer Inst | 2024 | https://conductscience.org/library/papers/38400738 | PubMed |
| 5 | 22759508 | Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. | Environ Health | 2012 | https://conductscience.org/library/papers/22759508 | PubMed |
| 6 | 27371184 | Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. | Lancet | 2016 | https://conductscience.org/library/papers/27371184 | PubMed |
| 7 | 16473739 | Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas. | Breast | 2006 | https://conductscience.org/library/papers/16473739 | PubMed |
| 8 | 38175589 | Epidemiology of Cancer. | Clin Chem | 2024 | https://conductscience.org/library/papers/38175589 | PubMed |
| 9 | 39869305 | Impact of Race/Ethnicity on Clinical and Genomic Characteristics, Trial Participation, and Genotype-Matched Therapy among Patients with Metastatic Breast Cancer. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/39869305 | PubMed |
| 10 | 31286336 | Systematic review on socioeconomic deprivation and survival in endometrial cancer. | Cancer Causes Control | 2019 | https://conductscience.org/library/papers/31286336 | PubMed |
| 11 | 39817679 | Cancer statistics, 2025. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/39817679 | PubMed |
| 12 | 38582094 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38582094 | PubMed |
| 13 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 14 | 35265202 | Platinum-based drugs for cancer therapy and anti-tumor strategies. | Theranostics | 2022 | https://conductscience.org/library/papers/35265202 | PubMed |
| 15 | 39133409 | Dietary Pattern and Cancer. | Cancer Treat Res | 2024 | https://conductscience.org/library/papers/39133409 | PubMed |
| 16 | 33082213 | PARP Inhibitors in Cancer Diagnosis and Therapy. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33082213 | PubMed |
| 17 | 40752271 | Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019. | Gynecol Oncol | 2025 | https://conductscience.org/library/papers/40752271 | PubMed |
| 18 | 38123181 | Using autoregressive integrated moving average models for time series analysis of observational data. | BMJ | 2023 | https://conductscience.org/library/papers/38123181 | PubMed |
| 19 | 35405346 | Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and premenopausal breast cancer including receptor status: prospective cohort study of nearly 500,000 Danish women. | Ann Epidemiol | 2022 | https://conductscience.org/library/papers/35405346 | PubMed |
| 20 | 38762327 | Findings from the Global Burden of Disease Study 2021. | Lancet | 2024 | https://conductscience.org/library/papers/38762327 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41234722
GET https://conductscience.org/api/papers/v1/41234722/references?page=2